Publications
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium2020 | First Faculty of Medicine
- Monocyte NOTCH2 expression predicts IFN-beta immunogenicity in multiple sclerosis patients2018 | First Faculty of Medicine
- Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis2024 | First Faculty of Medicine
- COVID-19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark2024 | First Faculty of Medicine
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis2022 | First Faculty of Medicine
- Magnetic resonance imaging findings in neuromyelitis optica spectrum disorders and disease associated with antibodies to myelin oligodendrocyte glycoprotein2022 | First Faculty of Medicine
- Pathological magnetic resonance imaging findings in myelin oligodendrocyte glycoprotein antibody-associated disease2022 | First Faculty of Medicine
- SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers2022 | First Faculty of Medicine
Loading network view...